期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫内膜浆液性乳头状癌的研究新进展 被引量：1

下载PDF
导出
摘要 子宫内膜癌是常见的妇科恶性肿瘤之一，分为I、Ⅱ两种类型．I型为雌激素依赖型，即常见的子宫内膜样腺癌；Ⅱ型为非雌激素依赖型。包括子宫内膜浆液性乳头状癌和子宫内膜透明细胞腺癌。子宫内膜浆液性乳头状癌（uterinepapillaryserouscarcinoma，UPSC）发病率不到子宫内膜癌的10％，
作者 李岩 耿晓星
机构地区 哈尔滨医科大学附属肿瘤医院
出处 《实用医学杂志》 CAS 北大核心 2014年第6期869-870,共2页 The Journal of Practical Medicine
基金 黑龙江省教育厅科学技术研究资助项目(编号:12511343)
关键词 子宫内膜浆液性乳头状癌 非雌激素依赖型 子宫内膜样腺癌 子宫内膜癌 妇科恶性肿瘤 透明细胞腺癌 发病率
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1del Carmen MG, Birrer M, Schorge JO. Uterine papillary serous cancer: A review of the literature [J]. Gynecol Oncol, 2012,127 (3) :651-661.
  • 2阳晓敏,阳志军.13例子宫浆液性乳头状囊腺癌临床病理分析[J].中国癌症防治杂志,2010,2(1):37-39. 被引量：3
  • 3Eavie O, Ben-Arie A, Gemer O. Possible association between BRCA-1 carriers and incidence of uterine papillary serous carcinoma (UPSC) [J]. lnt J Gynecol Cancer, 2008,18 (5) : 1150-1150.
  • 4Morgan J, Hoekstra AV, Chapman-Davis E, et al. Synuclein-ga (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma [ J ]. Gynecol Oncol, 2009,114 (2) : 293-298.
  • 5Zheng W, Liang SX, Yu H, et al. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features [J]. lnt J Surg Pathol, 2004, 12 (3) : 207-223.
  • 6Yi X, Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia [J]. Curt Opin Obstet Gynecol, 2008, 20( 1 ) : 20-25.
  • 7张溪,贾琳,Wenxin Zheng,孔北华.子宫内膜浆液性癌的发生、发展模式[J].中华妇产科杂志,2011,46(6):472-475. 被引量：3
  • 8Signorelli M, Guerra L, Buda A, et al. Role of the integrated PDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases [J]. Gynecol Oncol, 2009,115 (2) :231 - 235.
  • 9Moore KN, Fader AN. Uterine Papillary Serous Carcinoma [J]. Clin Obstet Gynecol, 2011,54(2) :278-291.
  • 10Ikeda Y, Oda K, Hiraike-Wada O, et al. Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer [J]. Oncol Rep, 2013,30(2):584-588.

二级参考文献63

  • 1孙晓光,石素胜,盛修贵,孙建衡.子宫乳头状浆液性癌与子宫内膜乳头状腺癌生物学行为的临床分析[J].中华妇产科杂志,1996,31(1):8-11. 被引量：6
  • 2Doll A,Abal M,Rigau M,et al.Novel molecular profiles of endometrial cancer-new light through old windows[J].J Steroid Biochem Mol Biol,2008,108:221-229.
  • 3Leslie KK,Laidler L,Albitar L,et al.Tyrosine kinase inhibitors in endometrial cancer[J].Int J Gynecol Cancer,2005,15:409-411.
  • 4Ai ZH,Yin LH,Zhou XR,et al.Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer[J].Cancer,2006,107:746-756.
  • 5Zhao SJ,Chen X J,Lu X,et al.Epidermal growth factor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma[J].Gynecol Oncol,2007,105:45-54.
  • 6Magdrdena B,Andrzeg S,Tomasz R,et al.Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium[J].Oncology Rep,2007,18:261-265.
  • 7Albitar L,Pickett G,Morgan M,et al.Models representing type Ⅰ and type Ⅱ human endometrial cancers:Ishikawa H and Hec50co cells[J].Gynecol Oncol,2007,106:52-64.
  • 8Scaltriti M,Baselga J.The epidermal growthfactor receptor pathway:a model for targeted therapy[J].Clin Cancer Res,2006,12:5268-5272.
  • 9Albitar L,Carter MB,Davies S,et al.Consequences of the loss of p53,RB1,and PTEN:relationship to gefitinib resistance in endometrial cancer[J].Gynecol Oncol,2007,106:94-104.
  • 10Jasa KV,Fyles A,Elit L,et al.Phase Ⅱ study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer:NCIC CTG IND-148[J].Proc Am Soc Clin Oncol,2004,22:5019.

共引文献5

同被引文献11

引证文献1

二级引证文献4

实用医学杂志
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部